Study of Safety and Immunogenicity of a Quadrivalent Influenza Vaccine in Healthy Adults Age 65-75 Years
Clinical trial NCT02247362 · UNKNOWN
Trial details
- NCT number
- NCT02247362
- Sponsor
- VaxInnate Corporation
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-01
- Primary completion
- 2015-04-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.